- Home
- CUTR vs AWH Comparison
CUTR vs AWH Comparison
Compare CUTR & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUTR
- AWH
- Stock Information
- Founded
- CUTR 1988
- AWH 1993
- Country
- CUTR United States
- AWH United States
- Employees
- CUTR N/A
- AWH N/A
- Industry
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AWH Medical/Dental Instruments
- Sector
- CUTR Health Care
- AWH Health Care
- Exchange
- CUTR Nasdaq
- AWH Nasdaq
- Market Cap
- CUTR 9.2M
- AWH 10.5M
- IPO Year
- CUTR 2004
- AWH N/A
- Fundamental
- Price
- CUTR $0.47
- AWH $0.44
- Analyst Decision
- CUTR Hold
- AWH Buy
- Analyst Count
- CUTR 3
- AWH 2
- Target Price
- CUTR $3.00
- AWH $4.40
- AVG Volume (30 Days)
- CUTR 1.6M
- AWH 93.3K
- Earning Date
- CUTR 03-20-2025
- AWH 11-14-2024
- Dividend Yield
- CUTR N/A
- AWH N/A
- EPS Growth
- CUTR N/A
- AWH N/A
- EPS
- CUTR N/A
- AWH N/A
- Revenue
- CUTR $155,210,000.00
- AWH $8,963,000.00
- Revenue This Year
- CUTR N/A
- AWH $11.87
- Revenue Next Year
- CUTR $4.61
- AWH $79.10
- P/E Ratio
- CUTR N/A
- AWH N/A
- Revenue Growth
- CUTR N/A
- AWH N/A
- 52 Week Low
- CUTR $0.28
- AWH $0.38
- 52 Week High
- CUTR $3.18
- AWH $5.65
- Technical
- Relative Strength Index (RSI)
- CUTR 54.47
- AWH 23.50
- Support Level
- CUTR $0.36
- AWH $0.38
- Resistance Level
- CUTR $0.50
- AWH $0.58
- Average True Range (ATR)
- CUTR 0.11
- AWH 0.07
- MACD
- CUTR 0.01
- AWH -0.02
- Stochastic Oscillator
- CUTR 20.16
- AWH 15.24
About CUTR Cutera Inc.
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.